Promising research trials surrounding the medication Retatrutide , specifically the 120 milligram formulation ZPHC ZPHC, reveal a significant effect on weight reduction and linked health conditions . Experts anticipate that this dual acting , affecting both GLP-1 and GIP receptors , may represent a substantial breakthrough in the approach of exces